Article
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design
13 Nov 2024
Abstract excerpt
Recent times have witnessed remarkable progress in cancer immunotherapy, drastically changing the cancer treatment landscape. Among the various immunotherapeutic approaches, adoptive cell therapy (ACT), particularly chimeric antigen receptor (CAR) T cell therapy, has emerged as a promising strategy to tackle cancer. CAR-T cells are genetically engineered T cells with synthetic receptors capable of recognising and...
Topics
Join the communities discussing this publication.
